Login / Signup

Xanthohumol microbiome and signature in adults with Crohn's disease (the XMaS trial): a protocol for a phase II triple-masked, placebo-controlled clinical trial.

Blake O LangleyJennifer Joan RyanJohn PhippsLita ButtolphBrenna BrayJoseph E AslanThomas O MetzJan F StevensRyan D Bradley
Published in: Trials (2022)
ClinialTrials.gov NCT04590508. Registered on October 19, 2020.
Keyphrases
  • phase ii
  • clinical trial
  • placebo controlled
  • double blind
  • phase iii
  • open label
  • study protocol
  • randomized controlled trial
  • phase ii study
  • rectal cancer